WithdrawnNot Applicable

Parasternal Subpectoral Plane Blocks for Cardiac Surgery Via a Midline Sternotomy

Stopped: no support received

0Started 2021-06

Plain-language summary

To better determine whether parasternal subpectoral plane blocks (PSPB) infusing bupivacaine for midline sternotomy decreases opioid consumption and pain scores. This is a prospective, blinded randomized controlled trial with 2 arms. 1 arm is the saline control arm, PSPB catheters will be placed with saline and continue to infuse saline. The other arm is bupivacaine study arm, PSPB catheters will be placed with bupivacaine and continue to infuse the local anesthetic.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male or Female
✓. Aged 18 - 80 years
✓. scheduled for primary elective cardiac surgery via median sternotomy
✓. willingness to undergo psychosocial testing
✓. willingness to participate in long-term follow up
✓. willingness to be randomized to receive local anesthetic or saline infusion through PSPB catheters
✓. access to an email and computer

Exclusion criteria

✕. Allergy to opioids
✕. allergy to bupivacaine
✕. emergency surgery
✕. unable to provide informed consent
✕. weight less than 50kg

What they're measuring

Opioid Consumption

Timeframe: 2 days

Trial details

NCT IDNCT04788056

SponsorBrigham and Women's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06

View on ClinicalTrials.gov More Pain, Postoperative trials